Sign in

CIK 0001661998

  • Non-accelerated filer
  • Smaller reporting company

Q32 Bio Inc.

Sign in to watch
Ticker
QTTB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473468154
Phone
+1 781-999-0232
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Former names
Q32 Bio Inc., Homology Medicines, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$320,396
in 6 filings

Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-10-01 TZIANABOS ARTHUR President & CEO Sale −12,400 $17.39 $216K 127,605
2019-10-01 TZIANABOS ARTHUR President & CEO Sale −100 $18.23 $2K 127,505
2019-10-01 Seymour Albert Chief Scientific Officer Sale −9,200 $17.38 $160K 181,850
2019-10-01 Seymour Albert Chief Scientific Officer Sale −100 $18.23 $2K 181,750
2019-09-05 Kelly Timothy P Sale −1,166 $19.94 $23K 0
2019-09-03 Smith W Bradford CFO, Treasurer & Secretary Exercise or conversion +6,000 $0.64 $4K 6,000
2019-09-03 Smith W Bradford CFO, Treasurer & Secretary Sale −6,000 $18.74 $112K 0
2019-09-03 Smith W Bradford CFO, Treasurer & Secretary Exercise or conversion · Employee Stock Option −6,000 139,404
2019-09-03 Seymour Albert Chief Scientific Officer Sale −9,300 $18.74 $174K 191,050
2019-09-03 TZIANABOS ARTHUR President & CEO Sale −12,500 $18.75 $234K 140,005
2019-08-01 Seymour Albert Chief Scientific Officer Sale −9,300 $17.37 $162K 200,350
2019-08-01 Smith W Bradford CFO, Treasurer & Secretary Exercise or conversion +6,000 $0.64 $4K 6,000
2019-08-01 Smith W Bradford CFO, Treasurer & Secretary Sale −6,000 $17.37 $104K 0
2019-08-01 Smith W Bradford CFO, Treasurer & Secretary Exercise or conversion · Employee Stock Option −6,000 145,404
2019-08-01 TZIANABOS ARTHUR President & CEO Sale −12,500 $17.37 $217K 152,505
2019-07-11 REICIN ALISE Director Grant or award · Option (Right to Buy) +31,160 31,160
2019-07-09 Rasty Siyamak Chief Operating Officer Sale −8,000 $20.00 $160K 222,707
2019-07-01 Seymour Albert Chief Scientific Officer Sale −9,200 $18.98 $175K 209,750
2019-07-01 Seymour Albert Chief Scientific Officer Sale −100 $19.56 $2K 209,650
2019-07-01 Smith W Bradford CFO, Treasurer & Secretary Exercise or conversion +6,000 $0.64 $4K 6,000

Page 20 of 25 · 492 trades